AddLife AB — Cyborg Score 7/10

Solid
Life Sciences & Medical Technology Distribution

Strategic Profile

AddLife enters 2026 with improved profitability, a strong balance sheet, and increased acquisition activity, while maintaining positive EBITA margin development. The company leverages a European footprint spanning multiple countries to serve publicly funded healthcare, research institutions, and pharmaceutical sectors, positioning itself as a specialized provider in diagnostics, biomedical research, and medical device solutions.

Cyborg Score Rationale

AddLife enters 2026 with improved profitability and strong balance sheet, alongside increased acquisition activity. The company benefits from a long operational history, diversified geographic presence, and recurring revenue from healthcare and research sectors. However, its mid-sized market capitalization and exposure to healthcare spending cycles present some volatility.

Top Insights

  • Strong entering 2026: improved profitability, strong balance sheet, and increased acquisition activity initiated
  • Labtech segment drives majority of revenue, offering analytical instruments and laboratory analysis services
  • Recent acquisitions include Opitek (patient positioning systems) and Pharmacold (refrigeration technology for pharma/healthcare)
  • Operates across 11+ countries including UK, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany

Named Competitors

  • Diagnostic and Laboratory Equipment — Global life sciences equipment and services
  • Medical Device Distribution — Nordic healthcare solutions and medical technology
  • Healthcare Consumables — Laboratory and medical consumables supplier

Recent Developments

  • (February 2026) Strong market capitalization of $1.88B with improved profitability and balance sheet entering 2026
  • (December 2025) Expanded Hepro presence in Sweden and secured new contract with Værnesregionen covering 35 municipalities
  • (2025) Acquired Pharmacold A/S, leading Danish refrigeration technology specialist for pharmaceutical and healthcare sectors
  • (2025) Acquired Opitek International ApS, Danish MedTech company specializing in patient positioning solutions

Open the full interactive AddLife AB report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →